Adaptive Biotechnologies (ADPT) News Today $4.42 -0.06 (-1.34%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Short Interest in Adaptive Biotechnologies Co. (NASDAQ:ADPT) Decreases By 5.5%November 20 at 2:39 AM | americanbankingnews.comComparing Tarsus Pharmaceuticals (NASDAQ:TARS) and Adaptive Biotechnologies (NASDAQ:ADPT)November 20 at 1:57 AM | americanbankingnews.comBalanced Hold Recommendation for Adaptive Biotechnologies Amid Positive Performance and External ChallengesNovember 19 at 7:25 AM | markets.businessinsider.comWilliam Blair Has Positive Forecast for ADPT FY2024 EarningsNovember 19 at 3:23 AM | americanbankingnews.comComparing Adaptive Biotechnologies (NASDAQ:ADPT) & Ginkgo Bioworks (NYSE:DNA)November 19 at 1:18 AM | americanbankingnews.comWhat is William Blair's Estimate for ADPT FY2024 Earnings?Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) - Stock analysts at William Blair boosted their FY2024 EPS estimates for shares of Adaptive Biotechnologies in a report released on Thursday, November 14th. William Blair analyst A. Brackmann now anticipates that the company will post earniNovember 18 at 2:46 AM | marketbeat.comShort Interest in Adaptive Biotechnologies Co. (NASDAQ:ADPT) Declines By 5.5%Adaptive Biotechnologies Co. (NASDAQ:ADPT - Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 31st, there was short interest totalling 8,960,000 shares, a decrease of 5.5% from the October 15th total of 9,480,000 shares. Based on an average daily volume of 1,050,000 shares, the short-interest ratio is presently 8.5 days.November 18 at 2:19 AM | marketbeat.comSumitomo Mitsui Trust Group Inc. Acquires 834,253 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)Sumitomo Mitsui Trust Group Inc. lifted its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 12.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,733,884 shares of the company's sNovember 16, 2024 | marketbeat.comPiper Sandler Issues Positive Forecast for Adaptive Biotechnologies (NASDAQ:ADPT) Stock PriceNovember 14, 2024 | americanbankingnews.comAdaptive Biotechnologies (ADPT) Receives a Buy from ScotiabankNovember 13, 2024 | markets.businessinsider.comAdaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 12.7% After Analyst UpgradeNovember 13, 2024 | americanbankingnews.comAdaptive Biotechnologies price target raised to $7 from $6 at Piper SandlerNovember 11, 2024 | markets.businessinsider.comJ.P. Morgan Remains a Buy on Adaptive Biotechnologies (ADPT)November 11, 2024 | markets.businessinsider.comAdaptive Biotechnologies (NASDAQ:ADPT) Trading 12.7% Higher After Analyst UpgradeAdaptive Biotechnologies (NASDAQ:ADPT) Trading 12.7% Higher Following Analyst UpgradeNovember 11, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $7.00Piper Sandler increased their price objective on shares of Adaptive Biotechnologies from $6.00 to $7.00 and gave the company an "overweight" rating in a research report on Monday.November 11, 2024 | marketbeat.comAdaptive Biotechnologies’ Q3 2024 Financial Performance OverviewNovember 9, 2024 | markets.businessinsider.comAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up Following Better-Than-Expected EarningsAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up on Earnings BeatNovember 8, 2024 | marketbeat.comAdaptive Biotechnologies sees FY MRD business revenue $143 M-$145MNovember 8, 2024 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Adaptive Biotechnologies (ADPT)November 8, 2024 | markets.businessinsider.comARK Investment Management LLC Purchases 189,134 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)ARK Investment Management LLC lifted its position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 1.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,601,134 shares ofNovember 8, 2024 | marketbeat.comAdaptive Biotechnologies Q3 Loss Decreases, Beats EstimatesNovember 8, 2024 | markets.businessinsider.comAdaptive Biotechnologies Reports Third Quarter 2024 Financial ResultsNovember 8, 2024 | markets.businessinsider.comAdaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ...November 8, 2024 | finance.yahoo.comAdaptive Biotechnologies Corporation (ADPT) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comAdaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell LymphomaNovember 7, 2024 | globenewswire.comEarnings To Watch: Adaptive Biotechnologies Corp (ADPT) Reports Q3 2024 ResultNovember 6, 2024 | finance.yahoo.comNovember 2024's Top US Penny Stocks With Growth PotentialNovember 2, 2024 | finance.yahoo.comAdaptive Biotechnologies (ADPT) Scheduled to Post Earnings on ThursdayAdaptive Biotechnologies (NASDAQ:ADPT) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=634338)October 31, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Stock Price Down 3% - What's Next?Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Down 3% - Should You Sell?October 16, 2024 | marketbeat.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Given Consensus Rating of "Moderate Buy" by AnalystsShares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the six brokerages that are covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold rating and four have given a buy rating to the coOctober 16, 2024 | marketbeat.comAdaptive Research Launches Decentralized Clinical Trial in Parkinson's DiseaseOctober 15, 2024 | tmcnet.comMaintaining Hold on Adaptive Biotechnologies Amidst Gradual Market Adoption and Competitive ChallengesOctober 15, 2024 | markets.businessinsider.comAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up - Time to Buy?Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up - What's Next?October 14, 2024 | marketbeat.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Stock Position Lifted by AQR Capital Management LLCAQR Capital Management LLC grew its stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 244.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 182,076 shares of the company's stoOctober 14, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Down - What's Next?Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Down - Time to Sell?October 10, 2024 | marketbeat.comAlgert Global LLC Sells 103,163 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)Algert Global LLC lowered its stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 61.6% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 64,323 shares of the compOctober 10, 2024 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Trading Down 4.8% - Here's WhyAdaptive Biotechnologies (NASDAQ:ADPT) Trading Down 4.8% - Time to Sell?October 9, 2024 | marketbeat.comFrenship ISD hosts Special Education Adaptive Field DayOctober 9, 2024 | msn.comAdaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024October 9, 2024 | globenewswire.comFrenship ISD hosts Special Education Adaptive Field Day to create inclusionOctober 9, 2024 | msn.comAdaptive Biotechnologies (NASDAQ:ADPT) Hits New 12-Month High - Should You Buy?Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 52-Week High - Here's WhyOctober 4, 2024 | marketbeat.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Acquired by Millennium Management LLCMillennium Management LLC grew its holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 1,008.3% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 9,262,341 shares of the company's stock after acquiring an additional 8,426,October 3, 2024 | marketbeat.comDREAM Adaptive Recreation receives generous gift from Lesar familySeptember 27, 2024 | yahoo.comAdaptive Biotechnologies Shares Rise After EU Certification for Lymphoid Test clonoSEQSeptember 27, 2024 | marketwatch.comFinally, hi-res Bluetooth on your iPhone: this cheap, tiny dongle adds aptX Adaptive and LDAC to any USB-C deviceSeptember 26, 2024 | msn.comFederated Hermes Inc. Sells 1,244,445 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)Federated Hermes Inc. reduced its stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 95.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 57,272 shares of the company's stock aSeptember 25, 2024 | marketbeat.comAdaptive waterski competition underway in Polk CountySeptember 21, 2024 | msn.comOshkosh North and West host homecoming kickball game for special needs students in Adaptive PESeptember 21, 2024 | msn.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Purchased by Rubric Capital Management LPRubric Capital Management LP lifted its stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 33.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 14,000,000 shares of the company's stock after purcSeptember 21, 2024 | marketbeat.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Given Average Recommendation of "Moderate Buy" by BrokeragesAdaptive Biotechnologies Co. (NASDAQ:ADPT - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the six research firms that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and four have given a buy rating toSeptember 21, 2024 | marketbeat.com Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Email Address My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report... The Next SpaceX Pre-IPO ADPT Media Mentions By Week ADPT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADPT News Sentiment▼0.810.45▲Average Medical News Sentiment ADPT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADPT Articles This Week▼134▲ADPT Articles Average Week Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Kodiak Sciences News Today Scholar Rock News Today Iovance Biotherapeutics News Today Twist Bioscience News Today CG Oncology News Today Apogee Therapeutics News Today Beam Therapeutics News Today Recursion Pharmaceuticals News Today Tarsus Pharmaceuticals News Today Immunocore News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADPT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptive Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
